Literature DB >> 10836132

Drug discovery in the next millennium.

E H Ohlstein1, R R Ruffolo, J D Elliott.   

Abstract

Selection and validation of novel molecular targets have become of paramount importance in light of the plethora of new potential therapeutic drug targets that have emerged from human gene sequencing. In response to this revolution within the pharmaceutical industry, the development of high-throughput methods in both biology and chemistry has been necessitated. This review addresses these technological advances as well as several new areas that have been created by necessity to deal with this new paradigm, such as bioinformatics, cheminformatics, and functional genomics. With many of these key components of future drug discovery now in place, it is possible to map out a critical path for this process that will be used into the new millennium.

Entities:  

Mesh:

Year:  2000        PMID: 10836132     DOI: 10.1146/annurev.pharmtox.40.1.177

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  14 in total

Review 1.  Molecular approaches to contraceptive development.

Authors:  U Natraj
Journal:  J Biosci       Date:  2001-11       Impact factor: 1.826

2.  TTD: Therapeutic Target Database.

Authors:  X Chen; Z L Ji; Y Z Chen
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

Review 3.  Tools for microwave-assisted parallel syntheses and combinatorial chemistry.

Authors:  Matthias Nüchter; Bernd Ondruschka
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

4.  Synthesis and selection of de novo proteins that bind and impede cellular functions of an essential mycobacterial protein.

Authors:  Alka Rao; Geeta Ram; Adesh Kumar Saini; Reena Vohra; Krishan Kumar; Yogendra Singh; Anand Ranganathan
Journal:  Appl Environ Microbiol       Date:  2006-12-22       Impact factor: 4.792

5.  Toxin detection based on action potential shape analysis using a realistic mathematical model of differentiated NG108-15 cells.

Authors:  Dinesh K Mohan; Peter Molnar; James J Hickman
Journal:  Biosens Bioelectron       Date:  2006-02-03       Impact factor: 10.618

6.  Update of TTD: Therapeutic Target Database.

Authors:  Feng Zhu; BuCong Han; Pankaj Kumar; XiangHui Liu; XiaoHua Ma; Xiaona Wei; Lu Huang; YangFan Guo; LianYi Han; ChanJuan Zheng; YuZong Chen
Journal:  Nucleic Acids Res       Date:  2009-11-20       Impact factor: 16.971

7.  Multi-algorithm and multi-model based drug target prediction and web server.

Authors:  Ying-tao Liu; Yi Li; Zi-fu Huang; Zhi-jian Xu; Zhuo Yang; Zhu-xi Chen; Kai-xian Chen; Ji-ye Shi; Wei-liang Zhu
Journal:  Acta Pharmacol Sin       Date:  2014-02-03       Impact factor: 6.150

8.  Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond.

Authors:  Y Ding; C E Lawrence
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

9.  Discovery of CCL18 antagonist blocking breast cancer metastasis.

Authors:  Yujie Liu; Huaqin Zheng; Qian Li; Shunying Li; Hongna Lai; Erwei Song; Ding Li; Jingqi Chen
Journal:  Clin Exp Metastasis       Date:  2019-05-06       Impact factor: 5.150

10.  Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery.

Authors:  Feng Zhu; Zhe Shi; Chu Qin; Lin Tao; Xin Liu; Feng Xu; Li Zhang; Yang Song; Xianghui Liu; Jingxian Zhang; Bucong Han; Peng Zhang; Yuzong Chen
Journal:  Nucleic Acids Res       Date:  2011-09-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.